Neurology and Neurosurgery

Episodes 65-80 of 317

How DDL-920 Could Help Restore Cognitive Function in Alzheimer's Patients
How DDL-920 Could Help Restore Cognitive Function in Alzheimer's Patients
NeuroFrontiers
How DDL-920 Could Help Restore Cognitive Function in Alzheimer's Patients
- Ashley Baker, MSN, PMHNP
- Istvan Mody, PhD
Evaluating Endocrine Complications in DMD Patients: Findings from a Survey
Evaluating Endocrine Complications in DMD Patients: Findings from a Survey
NeuroFrontiers
Evaluating Endocrine Complications in DMD Patients: Findings from a Survey
- Charles Turck, PharmD, BCPS, BCCCP
- Nadia Merchant, MD
- Melody Shi, MD
- Despoina Galetaki, MD
Optimizing Nutritional Support for Patients with Duchenne Muscular Dystrophy
Optimizing Nutritional Support for Patients with Duchenne Muscular Dystrophy
NeuroFrontiers
Optimizing Nutritional Support for Patients with Duchenne Muscular Dystrophy
Public Health Disparities in Alzheimer's Disease and Brain Health
Public Health Disparities in Alzheimer's Disease and Brain Health
NeuroFrontiers
Public Health Disparities in Alzheimer's Disease and Brain Health
Managing NF1 PN with this First and Only FDA-Approved Treatment Option
Managing NF1 PN with this First and Only FDA-Approved Treatment Option
NeuroFrontiers
Managing NF1 PN with this First and Only FDA-Approved Treatment Option
- Sandy Millman
- Pinki Prasad, MD
Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies
Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies
CME/CE
Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies
1.00 credit
- Perry Shieh, MD, PhD
1.00 credit
The Silent Struggle: Understanding ADHD's Impact on Girls and Women
The Silent Struggle: Understanding ADHD's Impact on Girls and Women
NeuroFrontiers
The Silent Struggle: Understanding ADHD's Impact on Girls and Women
- Kathleen Nadeau, PhD
Addressing ADHD in Women: A Guide to Diagnosis and Treatment
Addressing ADHD in Women: A Guide to Diagnosis and Treatment
NeuroFrontiers
Addressing ADHD in Women: A Guide to Diagnosis and Treatment
- Ashley Baker, MSN, PMHNP
- Kathleen Nadeau, PhD
Reviewing the Treatment Landscape for Duchenne Muscular Dystrophy
Reviewing the Treatment Landscape for Duchenne Muscular Dystrophy
NeuroFrontiers
Reviewing the Treatment Landscape for Duchenne Muscular Dystrophy
- Charles Turck, PharmD, BCPS, BCCCP
- Kay Davies, PhD, DBE FMedSci FRS
Understanding the Cardiovascular Risks of ADHD Medications
Understanding the Cardiovascular Risks of ADHD Medications
NeuroFrontiers
Understanding the Cardiovascular Risks of ADHD Medications
Understanding ADHD: Epidemiology, Impacts, and Management
Understanding ADHD: Epidemiology, Impacts, and Management
NeuroFrontiers
Understanding ADHD: Epidemiology, Impacts, and Management
On the Clinic Floor: Addressing the Most Critical Questions of Frontline Clinicians in Multiple Sclerosis Management
On the Clinic Floor: Addressing the Most Critical Questions of Frontline Clinicians in Multiple Sclerosis Management
CME/CE
On the Clinic Floor: Addressing the Most Critical Questions of Frontline Clinicians in Multiple Sclerosis Management
1.00 credit
- Robert Shin, MD, FANA, FAAN
- Enrique Alvarez, MD, PhD
- Jiwon Oh, MD, PhD, FRCPC
1.00 credit
ADHD in Older Adults: Key Diagnostic and Treatment Strategies
ADHD in Older Adults: Key Diagnostic and Treatment Strategies
NeuroFrontiers
ADHD in Older Adults: Key Diagnostic and Treatment Strategies
- Ashley Baker, MSN, PMHNP
- David Goodman, MD, LFAPA
The Multiple Faces of ATTRv-PN
The Multiple Faces of ATTRv-PN
MinuteCE®
The Multiple Faces of ATTRv-PN
1.00 program credit
- Sami Khella, MD
- Marcia Waddington-Cruz, MD, PhD
1.00 program credit
ATTRv-PN: A Complicated Disease With a Poor Prognosis
ATTRv-PN: A Complicated Disease With a Poor Prognosis
MinuteCE®
ATTRv-PN: A Complicated Disease With a Poor Prognosis
1.00 program credit
- John Berk, MD
- Sami Khella, MD
1.00 program credit
Advancing the Treatment of ATTRv-PN: What's in the Pipeline?
Advancing the Treatment of ATTRv-PN: What's in the Pipeline?
MinuteCE®
Advancing the Treatment of ATTRv-PN: What's in the Pipeline?
1.00 program credit
- John Berk, MD
- Sami Khella, MD
1.00 program credit

5/10

Neurology and Neurosurgery

Episodes 65-80 of 317

NEED HELP?

Contact us

NEED HELP?

Contact us

Episodes 65-80 of 317

Title

Share on ReachMD